Abstract:Objective To examine the kinetics of plasma S100A12 and soluble receptor for advanced glycation end products (sRAGE) in infants and young children undergoing cardiopulmonary bypass ( CPB),and to investigate whether they could protective the occurrence of noninfectious pulmonary complication (NPC) after cardiac surgery.Methods This was a case-control study.The subjects included all children aged ＜3 years old who underwent cardiac surgery with CPB during the period from June 1st to July 31st 2011.The patient who showed pulmonary inflammation or had abnormal liver or renal function before surgery was excluded.The remain patients were divided into 2 groups according to whether they had developed NPC postoperatively.Twenty patients were grouped into NPC because they developed the complications of pleural effusion,chylothorax,partial lung collapse,pulmonary hypertensive crisis,airway disorders,pneumothorax,pneumomediastinum,or phrenic nerve palsy.Forty patients were categorized into the no-NPC group.Plasma concentrations of S100A12 and sRAGE were measured using ELISA at baseline,before CPB,immediately after CPB,1 h,12 h and 24 h after operation.Differences concentrations between two groups were analyzed with t test.A stepwise logistic regression analysis was used to indentify the independent risk factor for NPC.A P value ＜0.05 was considered statistically significant.Results Plasma levels of S100A12 and sRAGE dramatically increased immediately after CPB ( P ＜ 0.01 ).The levels of sRAGE dropped to lower than baseline level (P ＜0.05),while S100A12 was still at high level 24h after operation (P ＜0.01 ).Levels of S100A12 and sRAGE immediately after CPB in NPC group were significantly higher than the no-NPC group (P ＜ 0.05).Twenty-four hours after operation,levels of S100A12 were still higher in NPC group than no-NPC (P ＜ 0.01 ),while levels of sRAGE were similar in the two groups ( P ＞ 0.05 ).In the stepwise logistic regression analysis,plasma S100A12 level immediately after CPB remained as a independently predictor for postoperative NPC (OR =1.042,95％ CI:1.010 ～ 1.076,P =0.011 ).Levels of S100A12 immediately after CPB were positively associated with mechanical ventilation time ( r =0.47,P ＜ 0.01 ),duration of surgical Intensive Care Unit ( r =0.407,P =0.002) and hospital stay ( r =0.421,P =0.01 ).Conclusions Plasma levels of S100A12 and sRAGE were significantly increased immediately after CPB and the elevated plasma S100A12 immediately after CPB served as an early reliable biomarker of the occurrence and the prognosis of NPC after CPB in infants and young children.

The risk factors of capillary leak syndrome after extracorporeal bypass in infants

Risk factors for capillary leak syndrome in children with tetralogy after operation]

Detection of Intercellular Adhesion Molecule-1 during Pediatric Cardiopulmonary Bypass

Risk Factors and Outcomes for Congenital Diaphragmatic Hernia in Neonatal Intensive Care Unit Patients

Risk factors for increased mortality rate of newborns with congenital diaphragmatic hernia in the single medical center

Effects of Pulmonary Protective Solution Involved Ulinastatin on Lung Function after Cardioopulmonary Bypass

Analysis of Risk Factors for Acute Renal Injury in Infants and Young Children after Cardiopulmonary Bypass

Studying the Association of Plasma S100a12 and Noninfectious Pulmonary Complication in Infants and Young Children Following Cardiopulmonary Bypass

The Effect of Cardiopulmonary Bypass Duration on Renal Injury after Congenital Heart Surgery in Infants and Young Children.

Analysis of Risk Factors of Acute Renal Injury after Cardiac Surgery with Cardiopulmonary Bypass in Infants and Toddlers with Congenital Heart Disease

Risk factors of gastrointestinal bleeding after cardiopulmonary bypass in children: a retrospective study

The Role of Plasma Gelsolin in Cardiopulmonary Bypass Induced Acute Lung Injury in Infants and Young Children: a Pilot Study

Ultrasound findings and specific intrinsic blood volume expansion therapy for neonatal capillary leak syndrome: report from a multicenter prospective self-control study

Factors Associated With Prolonged Recovery After the Arterial Switch Operation for Transposition of the Great Arteries in Infants

Studying the association of plasma S100A12 and noninfectious pulmonary complication in infants and young children following cardiopulmonary bypass (HUM1P.305)

Effects of Circuit Residual Volume Salvage Reinfusion on the Postoperative Clinical Outcome for Pediatric Patients Undergoing Cardiac Surgery

Risk factors for long intensive care unit stay after cardiopulmonary bypass in children

Application of Modified Ultrafiltration on Cardiopulmonary Bypass in Children

ECG Abnormalities, Diastolic Blood Pressure, and Adverse Events After Systemic to Pulmonary Artery Shunt in Infants with Congenital Heart Disease

Assessment of postoperative risk factors for EEG abnormalities in routine clinical management after paediatric cardiopulmonary bypass

Persistent Liver Dysfunction in Pediatric Patients after Total Cavopulmonary Connection Surgery